Clinical Trial Update: Double-Blind Placebo-Controlled Trial of Riluzole in Pediatric Bipolar Disorder [Phase 2]

View source ↗

Summary

A Phase 2 double-blind, placebo-controlled trial of riluzole in pediatric bipolar disorder was terminated with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Bipolar Disorder

Drugs mentioned

• Riluzole (riluzole)

Snippet

Sponsor: National Institute of Mental Health (NIMH) | Conditions: Bipolar Disorder, Anxiety Disorders | Phase 2 | Status: TERMINATED | Results posted: 2013-08-23